510(k) Report

510(k) · Cleared

Cleared

Accu-Stat Home Drug Test for Marijuana, Cocaine, Amphetamine, Methamphetamine, Opiates, and Phencyclidine

K040629510(k) TraditionalCleared May 5, 200456-day reviewClass II21 CFR 862.3870

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Accu-Stat Diagnostics, Inc. · LDJ Enzyme Immunoassay, Cannabinoids

Cleared on May 5, 2004 as substantially equivalent to K993852 (Worldwide Medical Corp., 2000) and 1 other predicate after a 56-day review. Its family tree reaches back 1 generation to 2000.

Decided
May 5, 2004
Review
56 days
Class
Class II
Product code
LDJ
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K993852 (2000). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by generation 1 generation back: 1 other ancestor K993852 · First Check Home Drug Test Panel 4 · Worldwide Medical Corp. · 20000
  1. Root · 1 generation backK993852 First Check Home Drug Test Panel 4Worldwide Medical Corp. · 2000
  2. This deviceK040629 Accu-Stat Home Drug Test for Marijuana, Cocaine, Amphetamine…Accu-Stat Diagnostics, Inc. · 2004
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K993852First Check Home Drug Test Panel 4Worldwide Medical Corp.2000—
0 (this device)K040629Accu-Stat Home Drug Test for Marijuana, Cocaine, Amphetamine, Methamphetamine…Accu-Stat Diagnostics, Inc.2004—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
FIG. 1 — Lineage of K040629, 2000–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LDJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LDJ device

  1. #1 K232732 Rapid Marijuana (THC) Test Strip 20, Rapid…score 9.4 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K993852First Check Home Drug Test Panel 4
Summary page 1
…(OPI), and Phencyclidine (PCP) is substantially equivalent to the First Check® Home Drug Test for Marijuana, Cocaine, Methamphetamine, & Opiates (K993852), and the Phamatech At HomeTM Drug Test for Amphetamine, Methamphetamine (Ecstasy), Marijuana, Cocaine, a…
Worldwide Medical Corp.2000—
*K003858Modification to at Home Drug Test, Models 9150, 9068, and 9175
Summary page 1
…hetamine, & Opiates (K993852), and the Phamatech At HomeTM Drug Test for Amphetamine, Methamphetamine (Ecstasy), Marijuana, Cocaine, and Opiates (K003858), and other commercially available drug screening tests that qualitatively measure the presence of target…
Phamatech2001—
†K020313Acon One Step Multi-Drug Multi-Line Screen Test Card; Acon One Step Multi-Drug…Acon Laboratories Co.2002—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.

How does its category compare?

All LDJ devices

LDJ Enzyme Immunoassay, Cannabinoids: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LDJ

2in 2024

2008: 22009: 12011: 42012: 42013: 32014: 22015: 32016: 12019: 12023: 12024: 2
2007high 4 (2011) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LDJ

48in 2015

2011: 219 days median2012: 193 days median2013: 162 days median2015: 48 days median
2007high 219 (2011) · low 48 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LDJ

1in 2023

2008: 42023: 1
2007high 4 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LDJ

1in 2015

2015: 1
2007high 1 (2015) · low 0 (2007)2025

MAUDE reports naming product code LDJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—40
20091—00
20100—00
2011421900
2012419300
2013316200
20142—00
201534801
20161—00
20170—00
20180—00
20191—00
20200—00
20210—00
20220—00
20231—10
20242—00
20250—00
20260—0—

What is it indicated for?

The Accu-Stat TM Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP) is a single-unit screening test for the rapid detection of two to six of the above drugs in human urine. The designated cut-off concentrations for these drugs are as follows: Marijuana at 50 ng/ml, Cocaine at 300 ng/ml, Amphetamine at 1000 ng/ml, Methamphetamine at 1000 ng/ml, Opiates at 2000 ng/ml, and…

Read the full statement (119 words)

The Accu-Stat TM Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP) is a single-unit screening test for the rapid detection of two to six of the above drugs in human urine. The designated cut-off concentrations for these drugs are as follows: Marijuana at 50 ng/ml, Cocaine at 300 ng/ml, Amphetamine at 1000 ng/ml, Methamphetamine at 1000 ng/ml, Opiates at 2000 ng/ml, and Phencyclidine at 25 ng/ml. The tests are intended for over-the-counter (OTC) consumer use as the first step in a two step process that includes confirmatory testing of preliminary positive results. Information, along with the materials for shipping a portion of the urine specimen to the laboratory is provided.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K040629: Accu-Stat Home Drug Test for Marijuana, Cocaine, Amphetamine, Methamphetamine, Opiates, and Phencyclidine.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K040629

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026